Akso Health Group Stock

Equities

AHG

US98422P1084

Internet Services

Market Closed - Nasdaq 15:58:30 2024-05-16 EDT 5-day change 1st Jan Change
0.6413 USD -2.83% Intraday chart for Akso Health Group -14.49% -13.34%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2022 6.31M 8.59M Sales 2023 13.18M 17.95M Capitalization 8.12M 11.05M
Net income 2022 -16M -21.79M Net income 2023 -1M -1.36M EV / Sales 2022 8.54 x
Net Debt 2022 15.27M 20.8M Net Debt 2023 1.76M 2.4M EV / Sales 2023 0.75 x
P/E ratio 2022
-1.99 x
P/E ratio 2023
-4.31 x
Employees 12
Yield 2022 *
-
Yield 2023
-
Free-Float 98.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.83%
1 week-14.49%
Current month-14.49%
1 month-21.57%
3 months-56.67%
6 months-36.50%
Current year-13.34%
More quotes
1 week
0.60
Extreme 0.603
0.75
1 month
0.60
Extreme 0.603
1.07
Current year
0.60
Extreme 0.603
2.90
1 year
0.25
Extreme 0.2505
2.90
3 years
0.20
Extreme 0.2
22.39
5 years
0.20
Extreme 0.2
22.39
10 years
0.20
Extreme 0.2
51.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder 41 14-02-28
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 65 22-04-10
Founder 41 14-02-28
Chief Executive Officer - -
More insiders
Date Price Change Volume
24-05-16 0.6413 -2.83% 11 925
24-05-15 0.66 -0.51% 4,102
24-05-14 0.6634 -6.56% 19,862
24-05-13 0.71 +4.41% 1,113
24-05-10 0.68 -9.33% 51,277

Delayed Quote Nasdaq, May 16, 2024 at 03:58 pm

More quotes
Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others. The Company is also engaged in social e-commerce platform business, cancer therapy and radiotherapy oncology service provider business, and the sale of coronavirus disease 2019 (COVID-19) Rapid Antigen Tests.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW